ABVC BioPharma, Inc. Cash and Restricted Cash
ABVC BioPharma, Inc. (ECOC) had Cash and Restricted Cash of $31.94 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31.94K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $140.32K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.33M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $853.91K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $31.94K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $140.32K 10-Q · filed 2026-05-18 |
| 2025-12-31 | $1.33M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $853.91K 10-Q/A · filed 2026-03-03 |
| 2025-06-30 | $1.08M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $759.57K 10-Q · filed 2026-05-18 |
| 2024-12-31 | $863.82K 10-Q · filed 2026-08-12 |
| 2024-09-30 | $769.87K 10-Q/A · filed 2026-03-03 |
| 2024-06-30 | $742.77K 10-Q · filed 2025-08-13 |
| 2024-03-31 | $659.00K 10-Q · filed 2025-04-30 |
| 2023-12-31 | $716.78K 10-Q/A · filed 2026-03-03 |
| 2023-09-30 | $1.12M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $742.19K 10-Q · filed 2024-08-14 |
| 2023-03-31 | $1.79M 10-Q · filed 2024-05-17 |
| 2022-12-31 | $1.39M 10-K · filed 2025-04-15 |
| 2022-09-30 | $1.97M 10-Q · filed 2023-11-15 |
| 2022-06-30 | $3.60M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $3.43M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $6.57M 10-K · filed 2024-03-13 |
| 2021-09-30 | $4.45M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $1.66M 10-Q · filed 2022-08-15 |
| 2021-03-31 | $3.33M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $5.00M 10-K · filed 2023-03-31 |
| 2020-09-30 | $151.85K 10-Q · filed 2021-11-15 |
| 2020-06-30 | $406.37K 10-Q · filed 2021-08-12 |
| 2020-03-31 | $139.79K 10-Q · filed 2021-05-10 |
| 2019-12-31 | $160.44K 10-K · filed 2022-03-31 |
| 2019-09-30 | $1.05M 10-Q · filed 2020-11-17 |
| 2019-06-30 | $556.43K 10-Q · filed 2020-08-14 |
| 2019-03-31 | $997.43K 10-Q · filed 2020-06-29 |
| 2018-12-31 | $242.78K 10-K · filed 2021-03-16 |
| 2018-09-30 | $216.66K 10-Q · filed 2019-11-18 |
| 2017-12-31 | $406.84K 10-K · filed 2020-05-15 |